(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid,
atorvastatin,
atorvastatin calcium,
atorvastatin calcium anhydrous,
atorvastatin calcium hydrate,
atorvastatin calcium trihydrate,
atorvastatin, calcium salt,
CI 981,
CI-981,
CI981,
Lipitor,
liptonorm,
atorvastatin calcium trihydrate,
344423-98-9,
Totalip,
Torvast,
UNII-48A5M73Z4Q,
ATORVASTATIN CALCIUM,
Atorvastatin hemicalcium trihydrate,
48A5M73Z4Q,
Atorvastatin calcium [USAN],
Calcium (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate trihydrate,
Atorvastatin calcium salt trihydrate,
Lipitor (TN),
134523-03-8,
AC1LCVLW,
Atorvastatin calcium (USP),
CHEBI:2911,
AtorvastatinCalciumSaltTrihydrate,
DTXSID50110042,
SHZPNDRIDUBNMH-NIJVSVLQSA-L,
HMS3260O09,
KS-000012CI,
Tox21_500074,
Atorvastatin calcium hydrate (JP17),
CCG-221378,
KS-1031,
Lipitor, Atorvastatin calcium trihydrate,
NCGC00260759-01,
D02258,
J-019610,
1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, calcium salt (2:1), trihydrate, (betaR,deltaR)-,
calcium (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate trihydrate,
calcium bis{(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate} trihydrate,
Cardyl,
Sortis,
atorvastatin,
Lipitor,
Rotacor,
Storvas,
Tahor,
Ranbaxy's Storvas,
UNII-C0GEJ5QCSO,
Atorvastatin calcium anhydrous,
C66H70F2N4O10.Ca,
Atorvastatin calcium [USAN:USP],
DRG-0321,
CI 981,
CI-981,
CID656846,
YM 548,
344423-98-9 (calcium trihydrate),
C66-H70-F2-N4-O10.Ca,
PD 134298-38A,
1641H,
Calcium (betaR,deltaR)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2),